Durban International Clinical Research Site, Enhancing Care Foundation
Durban 4302
0 studies enrolling now · 5 studies all time
What they study most
HIV-1-infection, Juvenile Idiopathic Arthritis
Studies at this site
- Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV — Running, not enrolling
- Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 — Running, not enrolling
- Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated — Stopped early
- Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis — Completed
- Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance — Running, not enrolling